Table I.

Characteristics of the studies included in the systematic review

PCOSQ/ MPCOSQ scores at baseline	Emotional	4.2 ± 1.1	3.8 ± 1.4	4.2 ± 1.38	5.85 ± 1.33	4.40 ± 1.36	3.98 ± 1.8
	Menstrual	3.9 + 1.4	3.5 ± 1.5	3.77 ± 1.29	4.18 ± 1.70	4.07 ± 1.56	3.65 ± 1.48
	Infertility	4.7 ± 1.4	4.3 ± 1.6	3.78 ± 1.63	4.33 ± 1.95	4.38 ± 1.95	3.35 ± 1.88
	Hirsutism	2.9 ± 1.6	3.2 ± 1.6	3.28 ± 1.60	5.24 ± 2.21	3.89 ± 1.93	4.33 ± 2.04
	Weight	4.8 ± 1.8	4.1 ± 1.9	2.61 ± 1.58	6.20 ± 1.01	2.66 ± 1.80	2.94 ± 1.98
Questionnaires		PCOSQ, BDI, HADS, GHQ	PCOSQ, BDI, HADS, GHQ, STAI	PCOSQ	PCOSQ	PCOSQ, SF-36, GHQ-28, PIQ	PCOSQ, SF-36
PCOS diagnostic criteria		2003 Rotterdam criteria	2003 Rotterdam criteria	1990 NIH	2003 Rotterdam criteria	1990 NIH	N/A
Testosterone (nmol/L)		78.6 ± 31.3 (ng/dl)	N/A	N/A	N/A	N/A	40 (43.5)¥
FG score		8.7 ± 4.9	N/A	N/A	8.39 ± 4.28	N/A	46 (50)**
BMI		23.3 ± 4.8	24.7 ± 5.7	N/A	26.02 ± 4.03	33.6 ± 8.7	48 (54.2)*
Location		Turkey	Turkey	Canada, UK, USA	Iran	Australia	UK
No. of PCOS group		36	226	393	200	203	82
Study type		Prospective observational	Prospective Case-control	prospective randomized placebo-controlled blinded	observational cross-sectional	observational cross-sectional	observational cross-sectional
Authors		Cinar et al (2012)	Cinar et al (2011)	Guyatt et al (2004)	Bazarganipour et al (2012)	Ching et al (2007)	Jones et al (2004$)

^*BMI>28

^**Excessive body hair

^¥ Testosterone >2

^$ The scores of PCOSQ were transformed on a range from 0 (indicating worst health status) to 100 (best health status) for compare with the SF-36 in this study. We transformed to 0-6 again for comparison with another studies. Moreover, we add 1 to score of PCOSQ, because in another study range was1-7 but in this study was 0-6.